Chemokines in tumor development and progression

Experimental Cell Research

Volumn 318, Issue 2, 2012, Pages 95-102

  Mukaida, Naofumi ^a,b   Baba, Tomohisa ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Fibroblast; Inflammation; Invasion; Leukocyte; Metastasis; Neovascularization

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AZOXYMETHANE; CHEMOKINE; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; DEXTRAN SULFATE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1;

CARCINOGENESIS; CELL FUNCTION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CIRCULATING TUMOR CELL; DISEASE COURSE; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; GENE DELETION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LEUKOCYTE; LIVER CELL CARCINOMA; MESENCHYMAL STEM CELL; MYELODYSPLASTIC SYNDROME; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STELLATE CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

EID: 82855161257     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.10.012     Document Type: Review

References (76)

1. Moser B., Wolf M., Walz A., Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004, 25:75-84.
2. Fernandez E.J., Lolis E. Structure, function, and inhibition of chemokines. Annu. Rev. Pharmacol. Toxicol. 2002, 42:469-499.
3. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
4. Vandercappellen J., Van Damme J., Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008, 267:226-244.
5. Nomiyama H., Osada N., Yoshie O. The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev. 2010, 21:253-262.
6. Moepps B., Nuesseler E., Braun M., Gierschik P. A homolog of the human chemokine receptor CXCR1 is expressed in the mouse. Mol. Immunol. 2006, 43:897-914.
7. Borrello M.G., Alberti L., Fischer A., Degl'innocenti D., Ferrario C., Gabriboldi M., Marchesi F., Allavena P., Greco A., Collini P., Pilloti S., Cassinelli G., Bressan P., Fugazzola L., Mantovani A., Pierotti M.A. Induction of a proinflamamtory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl. Acad. Sci. USA 2005, 102:14825-14830.
8. Sparmann A., Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458.
9. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
10. Shioppa T., Uranchimeg B., Saccani A., Biswas S.K., Doni A., Rapisarda A., Bernasconi S., Saccani A., Nebuloni M., Vago L., Mantovani A., Melillo G., Sica A. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 2003, 198:1391-1402.
11. Hold G.L., El-Omar E.M. Genetic aspects of inflammation and cancer. Biochem. J. 2008, 410:225-235.
12. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev. 2010, 24:2463-2479.
13. Kuilman T., Michaloglou C., Vredeveld L.C., Douma S., van Doorn R., Desmet C.J., Aarden L.A., Mooi W.J., Peeper D.S. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031.
14. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., Fumagalli M., Da Costa M., Brown C., Popov N., Takatsu Y., Melamed J., d'Adda di Fagagna F., Bernard D., Hernando E., Gil J. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008, 133:1006-1018.
15. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
16. Bertran E., Caja L., Navarro E., Sancho P., Mainez J., Murillo M.M., Vinyals A., Fabra À., Fabregat I. Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-β. Cell. Singal. 2009, 21:1595-1606.
17. Bates R.C., Deleo M.J., Mercurio A.M. The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR1-mediated chemotaxis. Exp. Cell Res. 2004, 299:315-324.
18. Fernando R.I., Castillo M.D., Litzinger M., Hamilton D.H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011, 71:5296-5306.
19. Allavena P., Germano G., Marchesi F., Mantovani A. Chemokines in cancer related inflammation. Exp. Cell Res. 2011, 317:664-673.
20. Kitadai Y., Haruma K., Mukaida N., Ohmoto Y., Matsutani N., Yasui W., Yamamoto S., Sumii K., Kajiyama G., Fidler I.J., Tahara E. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin-8. Clin. Cancer Res. 2000, 6:2735-2740.
21. Wang B., Hendricks D.T., Wamunyokoli F., Parker M.I. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res. 2006, 66:3071-3077.
22. Singh S., Nannuru K.C., Sadanandam A., Varney M.L., Singh R.K. CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Brit. J. Cancer 2009, 100:1638-1646.
23. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004, 4:540-550.
24. Teicher B.A., Fricker S.P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res. 2010, 16:2927-2931.
25. Righi E., Kashiwagi S., Yuan J., Santosuosso M., Leblanc P., Ingraham R., Forbes B., Edelblute B., Collette B., Xing D., Kowalski M., Mingari M.C., Vianello F., Birrer M., Orsulic S., Dranoff G., Poznanasky M.C. CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res. 2011, 71:5522-5534.
26. Messmer D., Fecteau J.-F., O'Hayre M., Bharati I.S., Handel T.M., Kipps T.J. Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib. Blood 2011, 117:882-889.
27. Zhang Y., Zhao H., Zhao D., Sun L., Zhi Y., Wu X., Huang W., Da W. SDF-1/CXCR4 axis in myelodysplastic syndromes: correlation with angiogenesis and apoptosis. Leukemia Res. 2011, (doi:10.1016/j.leukres.2011.06.017).
28. Ghadjar P., Rubie C., Aebersold D.M., Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int. J. Cancer 2009, 125:741-745.
29. Darash-Yahana M., Gillespie J.W., Hewitt S.M., Chen Y.Y., Maeda S., Stein I., Singh S.P., Bedolla R.B., Peled A., Troyer D.A., Pikarsky E., Karin M., Farber J.M. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PlosOne 2009, 4:e6695.
30. Murakami T., Cardones A.R., Finkelstein S.E., Restifo N.P., Klaunberg B.A., Nestle F.O., Castillo S.S., Dennis P.A., Hwang S.T. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J. Exp. Med. 2003, 198:1337-1347.
31. Wang J., Seethala R.R., Zhang Q., Gooding W., van Waes C., Hasegawa H., Ferris R.L. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy. J. Natl. Cancer Int. 2008, 100:502-512.
32. Maňes S., Mira E., Colomer R., Montero S., Real L.M., Gómez-Moutón C., Jimnez-Baranda S., Garzón A., Lacalle R.A., Harshman K., Ruz A., Martnez-A C. CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J. Exp. Med. 2003, 198:1381-1389.
33. Lu P., Nakamoto Y., Nemoto-Sasaki Y., Fujii C., Wang H., Hashii M., Ohmoto Y., Kaneko S., Kobayashi K., Mukaida N. Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas. Am. J. Pathol. 2003, 162:1249-1258.
34. Kim M.Y., Oskarsson T., Acharyya S., Nguyen D.X., Zhang X.H., Norton L., Massagu J. Tumor self-seeding by circulating cancer. cells 2009, 139:1315-1326.
35. Yoshie O., Fujisawa R., Nakayama T., Harasawa H., Tago H., Izawa D., Hieshima K., Tatsumi Y., Matsushima K., Hasegawa H., Kanamaru A., Kamihira S., Yamada Y. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002, 99:1505-1511.
36. Tobinai K. Clinical trials for human T-cell lymphotropic virus type 1-associated peripheral T-cell lymphoma in Japan. Semin. Hematol. 2010, 47:S5-S7.
37. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verstegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
38. Buonamici S., Trimarchi T., Ruocco M.G., Reavie L., Cathelin S., Mar B.G., Klinakis A., Lukyanov Y., Tseng J.C., Sen F., Gehrie E., Li M., Newcomb E., Zavadil J., Meruelo D., Lipp M., Ibrahim S., Efstratiadis A., Zagzag D., Bromberg J.S., Dustin M.L., Aifantis I. CCR7 signaling as an essential regulator of CNS infiltration of T-cell leukaemia. Nature 2009, 459:1000-1004.
39. Amersi F.F., Terando A.M., Goto Y., Scolyer R.A., Thompson J.F., Tran A.N., Faries M.B., Morton D.L., Hoon D.S. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin. Cancer Res. 2008, 14:638-645.
40. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14:6735-6741.
41. Shields J.D., Fleury M.E., Yong C., Tomei A.A., Randolph G.J., Swartz M.A. Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 singaling. Cancer Cell 2007, 11:526-538.
42. Zhang X.H., Wang Q., Gerald W., Hudis C.A., Norton L., Smid M., Foekens J.A., Massagu J. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009, 16:67-78.
43. Kochetkova M., Kumar S., McColl S.R. Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ. 2009, 16:664-673.
44. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol. Med. 2010, 16:133-144.
45. Popivanova B.K., Kostadinova F.I., Furuichi K., Shamekh M.M., Kondo T., Wada T., Egashira K., Mukaida N. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 2009, 69:7884-7892.
46. Qian B.Z., Li J., Zhang H., Kitamura T., Zhang J., Campion L.R., Kaiser E.A., Snyder L.A., Pollard J.W. CCL2 recruits inflammatory monocytes to facilitae breast-tumour metastasis. Nature 2011, 475:222-225.
47. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
48. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009, 9:162-174.
49. Huang B., Lei Z., Zhao J., Gong W., Liu J., Chen Z., Liu Y., Li D., Yuan Y., Zhang G.M., Feng Z.H. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett. 2007, 252:86-92.
50. Sawanobori Y., Ueha S., Kurachi M., Shimaoka T., Talmadge J.E., Abe J., Shono Y., Kitabatake M., Kakimi K., Mukaida N., Matsushima K. Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 2008, 111:5457-5466.
51. + myeloid cells that promote metastasis. Cancer Cell 2008, 13:23-35.
52. Nihishikawa H., Sakaguchi S. Regulatory T cells in tumor immunity. Int. J. Cancer 2010, 127:759-767.
53. Facciabene A., Peng X., Hagemann I.S., Balint K., Barchetti A., Wang L.P., Gimotty P.A., Gilks C.B., Lai P., Zhang L., Coukos G. Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature 2011, 475:226-230.
54. Steer H.J., Lake R.A., Nowak A.K., Robinson B.W. Harnessing the immune response to treat cancer. Oncogene 2010, 29:6301-6313.
55. + cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study. Lancet Oncol. 2009, 10:877-884.
56. Pan J., Burdick M.D., Belperio J.A., Xue Y.Y., Gerard C., Sharma S., Dubinett S.M., Strieter R.M. CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J. Immunol. 2006, 176:1456-1464.
57. Meijer J., Ogink J., Kreike B., Nuyten D., de Visser K.E., Roos E. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Cancer Res. 2008, 68:4701-4708.
58. Iida N., Nakamoto Y., Baba T., Kakinoniki K., Li Y.Y., Wu Y., Matsushima K., Kaneko S., Mukaida N. Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner. J. Leukoc. Biol. 2008, 84:1001-1010.
59. Tsuchiyama T., Nakamoto Y., Sakai Y., Marukawa Y., Kitahara M., Mukaida N., Kaneko S. Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma. J. Immunol. 2007, 178:574-583.
60. Fidler I.J., Ellis E.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994, 79:185-188.
61. Keeley E.C., Mehrad B., Strieter R.M. Chemokines as mediators of tumor angiogenesis and neovascularization. Exp. Cell Res. 2011, 317:685-690.
62. + CXC chemokine-induced angiogenic activity. J. Immunol. 2000, 165:5269-5277.
63. Glvez B.G., Genis L., Matias-Romn S., Oblander S.A., Tryggvason K., Apte S.S., Arroyo A.G. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis. J. Biol. Chem. 2005, 280:1292-1298.
64. + endothelial cells. J. Immunol. 2001, 166:7571-7578.
65. Strasly M., Doronzo G., Cappello P., Valdembri D., Arese M., Mitola S., Moore P., Alessandri G., Giovarelli M., Bussolino F. CCL16 activates an angiogenic program in vascular endothelial cells. Blood 2004, 103:40-49.
66. Maione T.E., Gray G.S., Petro J., Hunt A.J., Donner A.L., Bauer S.I., Carson H.F., Sharpe R.J. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990, 247:77-79.
67. Romagnani P., Annunziato F., Lasagni L., Lazzeri E., Beltrame C., Francalanci M., Uguccioni M., Galli G., Cosmi L., Maurenzig L., Baggiolini M., Maggi E., Romagnani S., Serio M. Cell-cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 2001, 107:53-63.
68. Du J., Luan J., Liu H., Daniel T.O., Peiper S., Chen T.S., Yu Y., Horton L.W., Nanney L.B., Strieter R.M., Richmond A. Potential role for Duffy antigen chemokine binding-protein in angiogenesis and maintenance of homeostasis in response to stress. J. Leukoc. Biol. 2002, 71:141-153.
69. Rehman J., Li J., Orschell C.M., March K.L. Peripheral blood "pendothelial progenitor cells"p are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003, 107:1164-1169.
70. Gijsbers K., Gouwy M., Struyf S., Wuyts A., Proost P., Opdenakker G., Penninckx F., Ectors N., Geboes K., Van Damme J. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp. Cell Res. 2005, 303:331-342.
71. Räsänen K., Vaheri A. Activation of fibroblasts in cancer stroma. Exp. Cell Res. 2010, 316:2713-2722.
72. Mishra P., Banerjee D., Ben-Baruch A. Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J. Leukocyte Biol. 2011, 89:31-39.
73. Guo X., Oshima H., Kitamura T., Taketo M.M., Oshima M. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J. Biol. Chem. 2008, 283:19864-19871.
74. Wu Y., Li Y.Y., Matsushima K., Baba T., Mukaida N. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts, and promotes angiogenesis in murine lung metastasis process. J. Immunol. 2008, 181:6384-6393.
75. Matsusue R., Kubo H., Hisamori S., Okoshi K., Takagi H., Hida K., Nakano K., Itami A., Kawada K., Nagayama S., Sakai Y. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann. Surg. Oncol. 2009, 16:2645-2653.
76. Yang X., Lu P., Ishida Y., Kuziel W.A., Fujii C., Mukaida N. Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization. Int. J. Cancer 2006, 118:335-345.